Steris issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
02/05/2025 | STE | Steris | FY | 2025 | $9.05 | $9.15 | $9.06 | $5.45B | $5.45B | $5.49B | Get Alert |
11/06/2024 | STE | Steris | FY | 2025 | $9.05 | $9.25 | $9.16 | $5.47B | $5.52B | $5.50B | Get Alert |
08/06/2024 | STE | Steris | FY | 2025 | $9.05 | $9.25 | $9.14 | $5.47B | $5.52B | $5.49B | Get Alert |
05/08/2024 | STE | Steris | FY | 2025 | $9.05 | $9.25 | $9.33 | $5.47B | $5.52B | $5.67B | Get Alert |
02/07/2024 | STE | Steris | FY | 2024 | $8.60 | $8.70 | $8.67 | $5.45B | $5.50B | $5.44B | Get Alert |
11/07/2023 | STE | Steris | FY | 2024 | $8.60 | $8.80 | $8.75 | $5.40B | $5.45B | $5.44B | Get Alert |
08/01/2023 | STE | Steris | FY | 2024 | $8.60 | $8.80 | $8.68 | $5.40B | $5.45B | $5.33B | Get Alert |
05/10/2023 | STE | Steris | FY | 2024 | $8.55 | $8.75 | $8.75 | $5.30B | $5.35B | $5.14B | Get Alert |
02/08/2023 | STE | Steris | FY | 2023 | $8.00 | $8.10 | $8.43 | $4.86B | $4.86B | $4.94B | Get Alert |
11/09/2022 | STE | Steris | FY | 2023 | $8.40 | $8.60 | $8.49 | $4.95B | $4.95B | $4.98B | Get Alert |
08/02/2022 | STE | Steris | FY | 2023 | $8.40 | $8.60 | $8.70 | $5.00B | $5.00B | $5.12B | Get Alert |
05/11/2022 | STE | Steris | FY | 2023 | $8.55 | $8.75 | $8.19 | — | — | — | Get Alert |
02/08/2022 | STE | Steris | FY | 2022 | $7.85 | $7.95 | $7.73 | — | — | — | Get Alert |
11/02/2021 | STE | Steris | FY | 2022 | $7.60 | $7.85 | $7.72 | — | — | — | Get Alert |
08/09/2021 | STE | Steris | FY | 2022 | $7.60 | $7.85 | $7.41 | $4.60B | $4.60B | $4.33B | Get Alert |
05/18/2021 | STE | Steris | FY | 2022 | $7.40 | $7.65 | $7.00 | $4.50B | $4.50B | $3.74B | Get Alert |
04/27/2021 | STE | Steris | FY | 2021 | — | — | — | $3.10B | $3.10B | $3.26B | Get Alert |
The most recent guidance for Steris (STE) was reported on February 5, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $9.05 to $9.15, compared to the estimated EPS of $9.06. Additionally, Steris forecasted revenue between $5.45B and $5.45B for the quarter.
Browse guidance and forecast on all stocks.